18F-FDG-PET/CT in malignant mesothelioma
Keywords: مزوتلیوما بدخیم; 18F-FDG-PET/CT; Malignant mesothelioma; Radiation therapy planning; Treatment response; Prognosis
مقالات ISI مزوتلیوما بدخیم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: Looking from outside is not enough
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; PET/CT; Thoracoscopy; Pleural disease; Pleural cancer
Péricardite récidivante : traquer le mésotheliome péricardique primitif
Keywords: مزوتلیوما بدخیم; Péricardite récidivante; Mésothéliome malin; Hyperplasie mésothélialeRecurrent pericarditis; Malignant mesothelioma; Mesothelial hyperplasia
Peripheral lymphadenopathy as the initial manifestation of malignant mesothelioma in a child
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Lymphadenopathy; Childhood
ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma
Keywords: مزوتلیوما بدخیم; Epigenetic gene silencing; Malignant mesothelioma; ZIC1; Methylation; miRNA
Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; oligonucleotide array CGH; spectral karyotyping; homozygous deletions; tumor suppressors
Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Cisplatin susceptibility; Annexin A4; Biomarker; Proteomics;
The use of Raman spectroscopy to identify inorganic phases in iatrogenic pathological lesions of patients with malignant pleural mesothelioma
Keywords: مزوتلیوما بدخیم; Malignant Mesothelioma; micro-Raman spectroscopy; talc; phosphates; asbestos; pleurodesis
Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients
Keywords: مزوتلیوما بدخیم; MM, malignant mesothelioma; (NSCLC), non-small-cell lung cancer; NM, normal mesothelium; miRNAs, micro-RNAs; qRT-PCR, quantitative RT-PCRCirculating miR-126; Clinic validation; Malignant mesothelioma; Non-small-cell lung cancer; Relative qRT-PCR; Absolute
Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells
Keywords: مزوتلیوما بدخیم; CD24; CD26; Cancer stem cells; Malignant mesothelioma;
Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Prognosis; NLR; mGPS; EORTC score
DNA Repair Polymorphisms and Treatment Outcomes of Patients with Malignant Mesothelioma Treated with Gemcitabine-Platinum Combination Chemotherapy
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Polymorphism; DNA repair; Treatment outcome; Toxicity
Activated Leukocyte Cell-Adhesion Molecule (ALCAM) Promotes Malignant Phenotypes of Malignant Mesothelioma
Keywords: مزوتلیوما بدخیم; Activated leukocyte cell-adhesion molecule (ALCAM); Malignant mesothelioma; Migration; Invasion; Soluble isoform
Metallo-drugs in the treatment of malignant pleural mesothelioma
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Chemotherapy; Platinum drugs; Metal drugs; Chemoresistance;
Immunity and malignant mesothelioma: From mesothelial cell damage to tumor development and immune response-based therapies
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Vaccine; Immune response; MAb-based therapy; Innate immunity
Telomerase activity in pleural malignant mesotheliomas
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Telomerase; Alternative lengthening of telomeres; Immortalisation; Telomere maintenance mechanism; Pleura;
Crocidolite asbestos-induced signal pathway dysregulation in mesothelial cells
Keywords: مزوتلیوما بدخیم; MM; malignant mesothelioma; MAPK; mitogen-associated protein kinase; Immunoblot; Signaling network; Proteomics; Mesothelioma;
In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma
Keywords: مزوتلیوما بدخیم; Ascorbate; Combination index; Epigallocatechin-3-gallate; Gemcitabine; Isobolograms; Malignant mesothelioma; Synergistic combinations;
Identification of cancer stem cell markers in human malignant mesothelioma cells
Keywords: مزوتلیوما بدخیم; Side population; CD9; CD24; CD26; Cancer stem cells; Malignant mesothelioma
Platinum–bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis
Keywords: مزوتلیوما بدخیم; Bisphosphonates; Malignant mesothelioma; Platinum complexes; Drug targeting and delivery; Bifunctional drug candidates
Mesothelioma from Chrysotile Asbestos: Update
Keywords: مزوتلیوما بدخیم; Asbestos; Malignant Mesothelioma; Chrysotile; Asbestos-Related Diseases; Environmental Epidemiology; Occupational EpidemiologySMR, standardized mortality ratio; CI, confidence interval; OR, odds ratio
Advances in the biology of malignant pleural mesothelioma
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Molecular pathways; Targeted therapy
Role of Integrated 18-Fluorodeoxyglucose Position Emission Tomography-Computed Tomography in Patients Surveillance after Multimodality Therapy of Malignant Pleural Mesothelioma
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; PET-CT; Multimodality therapy; Surveillance
Well-differentiated papillary mesothelioma with invasion to the chest wall
Keywords: مزوتلیوما بدخیم; Well-differentiated papillary mesothelioma; Malignant mesothelioma; Asbestos; Pleura; Extrapleural pneumonectomy; Prognosis; Epithelial membrane antigen; p53
Urinary trypsin inhibitor suppresses migration of malignant mesothelioma
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Migration; Urinary trypsin inhibitor; Platelet-derived growth factor-D; Platelet-derived growth factor-β receptor
Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions
Keywords: مزوتلیوما بدخیم; Effusion cytology; Malignant mesothelioma; FISH; p16 gene; Ploidy;
IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology
Keywords: مزوتلیوما بدخیم; IMP3/L523S; Immunocytochemistry; Effusion cytology; Adenocarcinoma; Malignant mesothelioma
Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: A meta-analysis
Keywords: مزوتلیوما بدخیم; Accuracy; Diagnosis; Malignant mesothelioma; Mesothelin
A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro
Keywords: مزوتلیوما بدخیم; PLK-1; RNA interference; DNA-chimeric siRNA; Bisphosphonate; Malignant mesothelioma
Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter
Keywords: مزوتلیوما بدخیم; Mesothelin; Malignant mesothelioma; Promoter methylation; CpG island; Ms-SNuPE
Asbestos-Related Lung Disease
Keywords: مزوتلیوما بدخیم; Asbestos; Asbestos-related disease; Malignant mesothelioma; Lung cancer; Asbestosis; Mineral analysis
Benign and Malignant Mesothelial Proliferation
Keywords: مزوتلیوما بدخیم; Mesothelial proliferations; Malignant mesothelioma; Metastatic carcinoma; Pleural effusion;
Expression of Wilms tumor-1 protein and CD 138 in malignant mesothelioma of the tunica vaginalis
Keywords: مزوتلیوما بدخیم; Testicular neoplasms; Malignant mesothelioma; Wilms tumor-1 protein; CD138
Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?
Keywords: مزوتلیوما بدخیم; D2-40; Malignant mesothelioma; Lung adenocarcinoma; Benign mesothelial proliferations
Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related Benign Pleural Disease: An Observational Pilot Study
Keywords: مزوتلیوما بدخیم; 18F-fluorodeoxyglucose positron emission tomography-computed tomography; Asbestos; Pleural disease; Malignant mesothelioma; Diffuse pleural thickening; Benign asbestos-related pleural effusions
Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Insulin-like growth factor 1 receptor; AG1024; Cisplatin; Chemoresistance
Role of viral induced vascular endothelial growth factor (VEGF) production in pleural effusion and malignant mesothelioma
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; MDA5; RIG-I; Toll-like receptor 3; VEGF;
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
Keywords: مزوتلیوما بدخیم; Folate receptors; Serous effusions; Ovarian carcinoma; Breast carcinoma; Malignant mesothelioma; Survival
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810)
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Cisplatin; Gemcitabine; Chemotherapy; Phase II; Pleural disease;
Accuracy and reproducibility of pleural effusion cytology
Keywords: مزوتلیوما بدخیم; Diagnostic accuracy; Effusion cytology; Intra–interobserver agreement; Litigation and compensation; Malignant mesothelioma; Metastatic pleural carcinoma
Assessment of Biomarkers in asbestos-exposed workers as indicators of cancer risk
Keywords: مزوتلیوما بدخیم; Asbestos exposure; Asbestos-exposed workers; Carcinogenic risk; Malignant mesothelioma; Biomarkers;
Pharmacokinetic Analysis of Malignant Pleural Mesothelioma-Initial Results of Tumor Microcirculation and its Correlation to Microvessel Density (CD-34)
Keywords: مزوتلیوما بدخیم; Angiogenesis; malignant mesothelioma; dynamic contrast enhanced MRI; pharmacokinetic analysis; microvascular density; CD-34;
Malignant mesothelioma following thoracic radiotherapy for lung cancer
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Irradiation; Pleural mesothelioma; Lung cancer; Secondary malignancy
The Portsmouth thoracoscopy experience, an evaluation of service by retrospective case note analysis
Keywords: مزوتلیوما بدخیم; Thoracoscopy; Pleural effusion; Malignant mesothelioma; Asbestos; Pleural disease
Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM)
Keywords: مزوتلیوما بدخیم; EphA2; EphrinA1; Malignant mesothelioma; Receptor tyrosine kinase; Proliferation; ERK1/2
Combined CA125 and Mesothelin Levels for the Diagnosis of Malignant Mesothelioma
Keywords: مزوتلیوما بدخیم; CA125; malignant mesothelioma; mesothelin; SMRP; tumor markersAUC, area under the receiver operating characteristic curve; CI, confidence interval; ROC, receiver operator characteristic
Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma
Keywords: مزوتلیوما بدخیم; IAP; Malignant mesothelioma; Tumor progression; Serous effusions; Survival
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center
Keywords: مزوتلیوما بدخیم; Malignant mesothelioma; Extrapleural pneumonectomy; Pleurectomy; Decortication
The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion
Keywords: مزوتلیوما بدخیم; Immunocytochemistry; Pleural effusions; Malignant mesothelioma; Squamous cell carcinoma; Adenocarcinoma;
Tocopherol-associated protein-1 accelerates apoptosis induced by α-tocopheryl succinate in mesothelioma cells
Keywords: مزوتلیوما بدخیم; Apoptosis; Malignant mesothelioma; Tocopherol-associated protein; α-Tocopheryl succinate